The aim of this study was to evaluate the clinical features, pathological characteristics, and prognosis in myeloperoxidase (MPO)-antineutrophil cytoplasmic antibodies (ANCA)-associated glomerulonephritis (AAGN) with renal arteritis. The study involved 97 children from five pediatric clinical centers with MPO-AAGN who exhibited distinct clinical features. The patients were divided into AAGN-A+ and AAGN-A−, based on the presence or absence of arteritis, and the disparities in clinical, histopathological characteristics, and prognosis between the two groups was evaluated. In contrast to the AAGN-A− group, the children in the AAGN-A+ group exhibited more pronounced clinical symptoms and renal pathological injury. Arteritis positively moderately correlated with the serum creatinine, interleukin-6, urinary neutrophil gelatinase-associated lipocalin, negatively moderately correlated with serum complement C3. The renal survival rate in the AAGN-A+ group was significantly poorer than AAGN-A− group (χ2 = 4.278, p = 0.039). Arteritis showed a good predictive value for end-stage kidney disease (ESKD), and C3 deposition, ANCA renal risk score and arteritis were independent risk factors for the development of ESKD in children with MPO-AAGN. Arteritis is a significant pathological change observed in children with MPO-AAGN, and the formation of arteritis may be related to the inflammatory response and activation of the complement system.
AnXNWeiZNYaoXY, et al. Evaluating renal outcome of ANCA-associated renal vasculitis: comparative study of two histopathological scoring systems. Clin Exp Rheumatol2021; 39 Suppl129(2): 39–45.
2.
SaitoMSaitoAAbeF, et al. Evaluation of a newly proposed renal risk score for Japanese patients with ANCA-associated glomerulonephritis. Clin Exp Nephrol2022; 26(8): 760–769.
3.
HongYShiPLiuX, et al. Distinction between MPO-ANCA and PR3-ANCA-associated glomerulonephritis in Chinese patients: a retrospective single-center study. Clin Rheumatol2019; 38(6): 1665–1673.
4.
BajemaIMHagenECvan der WoudeFJ, et al. Wegener’s granulomatosis: a meta-analysis of 349 literary case reports. J Lab Clin Med1997; 129(1): 17–22.
5.
VizjakARottTKoselj-KajtnaM, et al. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis2003; 41(3): 539–549.
6.
HauerHABajemaIMvan HouwelingenHC, et al. European Vasculitis Study Group (EUVAS): renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int2002; 61(1): 80–89.
7.
ChenMYuFWangSX, et al. Renal histology in Chinese patients with anti-myeloperoxidase autoantibody positive Wegener’s granulomatosis. Nephrol Dial Transplant2007; 22(1): 139–145.
8.
EndoAHoshinoJSuwabeT, et al. Significance of small renal artery lesions in patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis. J Rheumatol2014; 41(6): 1140–1146.
9.
de LindvanWijngaardenRAHauerHAWolterbeekR, et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol2006; 17(8): 2264–2274.
10.
HakroushSTampeB.Incidence of arteritis and peritubular capillaritis in ANCA-associated vasculitis. J Am Soc Nephrol2021; 32(11): 2974–2975.
11.
BoudhabhayIDelestreFCoutanceG, et al. Reappraisal of renal arteritis in ANCA-associated vasculitis: clinical characteristics, pathology, and outcome. J Am Soc Nephrol2021; 32(9): 2362–2374.
12.
BrixSRNoriegaMTennstedtP, et al. Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Kidney Int2018; 94(6): 1177–1188.
13.
JennetteJCFalkRJBaconPA, et al. 2012 revised International Chapel Hill Consensus conference nomenclature of vasculitides. Arthritis Rheum2013; 65(1): 1–11.
14.
YooJKimHJAhnSS, et al. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis. Clin Exp Rheumatol2018; 36 Suppl 111(2): 85–87.
15.
CalatroniMConsonniFAllinoviM, et al. Prognostic factors and long-term outcome with ANCA-associated kidney vasculitis in childhood. Clin J Am Soc Nephrol2021; 16(7): 1043–1051.
16.
DolezalovaPPrice-KuehneFEÖzenS, et al. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis2013; 72(10): 1628–1633.
17.
LeveyAS.Defining AKD: the spectrum of AKI, AKD, and CKD. Nephron2022; 146(3): 302–305.
18.
RoufosseCSimmondsNClahsen-van GroningenM, et al. A 2018 Reference guide to the Banff Classification of renal allograft pathology. Transplantation2018; 102(11): 1795–1814.
19.
PietersTTFalkeLLNguyenTQ, et al. Histological characteristics of acute tubular injury during delayed graft function predict renal function after renal transplantation. Physiol Rep2019; 7(5): e14000.
20.
MasuzawaNNishimuraAMiharaY, et al. Clinicopathological analysis of ANCA-associated glomerulonephritis focusing on plasma cell infiltrate. Clin Exp Nephrol2019; 23(12): 1373–1381.
21.
HakroushSTampeDStröbelP, et al. Comparative histological subtyping of immune cell infiltrates in MPO-ANCA and PR3-ANCA glomerulonephritis. Front Immunol2021; 12: 737708.
22.
LinWShenCZhongY, et al. Glomerular immune deposition in MPO-ANCA associated glomerulonephritis is associated with poor renal survival. Front Immunol2021; 12: 625672.
23.
BerdenAEFerrarioFHagenEC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol2010; 21(10): 1628–1636.
24.
AkioKKunihiroYHirofumiM, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol2009; 13(6): 633–650.
25.
Casal MouraMFervenzaFCSpecksU, et al. Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant2022; 37(9): 1710–1721.
26.
SethiSHaasMMarkowitzGS, et al. Mayo Clinic/Renal Pathology Society Consensus Report on pathologic classification, diagnosis, and reporting of GN. J Am Soc Nephrol2016; 27(5): 1278–1287.
27.
YamagataKUsuiJSaitoC, et al. ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol2012; 16(4): 580–588.
28.
KorstenPBaierEHakroushS, et al. C-reactive protein levels are associated with complement C4 deposits and interstitial arteritis in ANCA-associated renal vasculitis. Int J Mol Sci2023; 24(4): 3072.
29.
NawataYEuguiEMLeeSW, et al. IL-6 is the principal factor produced by synovia of patients with rheumatoid arthritis that induces B-lymphocytes to secrete immunoglobulins. Ann N Y Acad Sci1989; 557: 230–238, discussion 239.
30.
WangQvan TimmerenMMPetersenAH, et al. Age-determined severity of anti-myeloperoxidase autoantibody-mediated glomerulonephritis in mice. Nephrol Dial Transplant2017; 32(2): 254–264.
31.
NagaoTKusunokiRIwamuraC, et al. Correlation of interleukin-6 and monocyte chemotactic protein-1 concentrations with crescent formation and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti-interleukin-6 receptor antibody or mizoribine. Microbiol Immunol2013; 57(9): 640–650.
32.
HakroushSTampeDBaierE, et al. Intrarenal synthesis of complement C3 localized to distinct vascular compartments in ANCA-associated renal vasculitis. J Autoimmun2022; 133: 102924.
